Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immune Thrombocytopenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06544499
What this trial is testing

Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
argenx 69
Large-scale testing (Phase 3)Study completedNCT01444417
What this trial is testing

Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

Who this might be right for
Idiopathic Thrombocytopenic PurpuraThrombocytopeniaThrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)+3 more
Amgen 62
Large-scale testing (Phase 3)Study completedNCT03939637
What this trial is testing

Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children

Who this might be right for
Immune Thrombocytopenia
Baylor College of Medicine 122
Large-scale testing (Phase 3)WithdrawnNCT02649504
What this trial is testing

Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Weill Medical College of Cornell University
Early research (Phase 1)Study completedNCT01586455
What this trial is testing

Human Placental-Derived Stem Cell Transplantation

Who this might be right for
Mucopolysaccharidosis IMucopolysaccharidosis VIAdrenoleukodystrophy+13 more
New York Medical College 43
Not applicableStudy completedNCT01549184
What this trial is testing

Retrospective Analysis of the Safety and Efficacy of Hydroxychloroquine in Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaSystemic Lupus Erythematosus
Henri Mondor University Hospital 40
Early research (Phase 1)Active Not RecruitingNCT07675226
What this trial is testing

Bioequivalence Study of SKI-O-703 in Healthy Adults Under Fed Conditions

Who this might be right for
Bioequivalence Study in Healthy SubjectsImmune Thrombocytopenia (ITP)Rheumatoid Arthritis (RA)
Oscotec Inc. 48
Post-approval studies (Phase 4)Study completedNCT00907478
What this trial is testing

Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP)

Who this might be right for
ThrombocytopeniaIdiopathic Thrombocytopenic Purpura
Amgen 169
Testing effectiveness (Phase 2)UnknownNCT03033199
What this trial is testing

Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Shandong University 60
Early research (Phase 1)Enrolling By InvitationNCT06723106
What this trial is testing

Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)

Who this might be right for
Antiphospholipid Syndrome (APS)Bullous Pemphigoid (BP)Behçet's Syndrome (BS)+3 more
Chugai Pharmaceutical 144
Testing effectiveness (Phase 2)Study completedNCT04217148
What this trial is testing

The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 132
Not applicableEnded earlyNCT04904276
What this trial is testing

Observational Study of Fostamatinib as Second Line Therapy in Adult Patients With Immune Thrombocytopenia (ITP) and Insufficient Response to a Prior Therapy

Who this might be right for
ITPImmune Thrombocytopenia
Rigel Pharmaceuticals 16
Early research (Phase 1)Looking for participantsNCT07072247
What this trial is testing

RN1201 Injection in the Treatment of Antibody-Mediated Diseases

Who this might be right for
Refractory Immune-mediated Platelet Transfusion RefractorinessRelapsed or Refractory Immune Thrombocytopenia
The First Affiliated Hospital of Soochow University 9
Large-scale testing (Phase 3)Ended earlyNCT04224688
What this trial is testing

Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
UCB Biopharma SRL 30
Not applicableUnknownNCT03377439
What this trial is testing

The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP

Who this might be right for
Immune Thrombocytopenia
Shandong University 400
Large-scale testing (Phase 3)Ended earlyNCT04200456
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
UCB Biopharma SRL 33
Not applicableStudy completedNCT00005570
What this trial is testing

An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers

Who this might be right for
Purpura, Thrombocytopenic, IdiopathicImmune Thrombocytopenic Purpura
National Heart, Lung, and Blood Institute (NHLBI) 200
Testing effectiveness (Phase 2)Looking for participantsNCT07297563
What this trial is testing

Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 160
Testing effectiveness (Phase 2)Study completedNCT02402998
What this trial is testing

Eltrombopag in Second Line Adult Primary Immune Thrombosytopenia

Who this might be right for
Primacy Immune Thrombocytopenia
Gruppo Italiano Malattie EMatologiche dell'Adulto 55
Post-approval studies (Phase 4)Study completedNCT02556814
What this trial is testing

Caffeic Acid Combining High-dose Dexamethasone in Management of ITP

Who this might be right for
Immune Thrombocytopenia
Shandong University 214
Next Page